For example, those with a monogenic cause of FSGS such as the presence of two high-risk APOL1 variants or type 4 collagen mutations (non-circulating factor) have minimal risks of recurrence post-transplant. This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.